123 related articles for article (PubMed ID: 10618556)
1. Rationale and design of the magnesium in coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction.
MAGIC Steering Committee
Am Heart J; 2000 Jan; 139(1 Pt 1):10-4. PubMed ID: 10618556
[TBL] [Abstract][Full Text] [Related]
2. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.
Magnesium in Coronaries (MAGIC) Trial Investigators
Lancet; 2002 Oct; 360(9341):1189-96. PubMed ID: 12401244
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty.
Santoro GM; Antoniucci D; Bolognese L; Valenti R; Buonamici P; Trapani M; Santini A; Fazzini PF
Am Heart J; 2000 Dec; 140(6):891-7. PubMed ID: 11099993
[TBL] [Abstract][Full Text] [Related]
4. Effect of magnesium sulfate pretreatment and significance of matrix metalloproteinase-1 and interleukin-6 levels in coronary reperfusion therapy for patients with acute myocardial infarction.
Shibata M; Ueshima K; Harada M; Nakamura M; Hiramori K; Endo S; Sato N; Mukaida H; Suzuki T; Suzuki T; Inada K
Angiology; 1999 Jul; 50(7):573-82. PubMed ID: 10431997
[TBL] [Abstract][Full Text] [Related]
5. Intravenous magnesium sulphate in acute myocardial infarction--is the answer "MAGIC"?
Smetana R; Stühlinger HG; Kiss K; Glogar DH
Magnes Res; 2003 Mar; 16(1):65-9. PubMed ID: 12735485
[TBL] [Abstract][Full Text] [Related]
6. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
Domanski M; Antman EM; McKinlay S; Varshavsky S; Platonov P; Assmann SF; Norman J
Control Clin Trials; 2004 Dec; 25(6):553-62. PubMed ID: 15588742
[TBL] [Abstract][Full Text] [Related]
7. Does magnesium therapy early in acute MI reduce mortality?
Phillips J; Krist A
J Fam Pract; 2003 Mar; 52(3):195, 199. PubMed ID: 12620172
[TBL] [Abstract][Full Text] [Related]
8. Magnesium in acute myocardial infarction: overview of available evidence.
Antman EM
Am Heart J; 1996 Aug; 132(2 Pt 2 Su):487-95; discussion 496-502. PubMed ID: 8694009
[TBL] [Abstract][Full Text] [Related]
9. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Woods KL; Fletcher S; Roffe C; Haider Y
Lancet; 1992 Jun; 339(8809):1553-8. PubMed ID: 1351547
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome.
Thögersen AM; Johnson O; Wester PO
Int J Cardiol; 1995 Apr; 49(2):143-51. PubMed ID: 7543083
[TBL] [Abstract][Full Text] [Related]
12. [Magnesium sulfate in acute myocardial infarction].
Balli E; Giomi A; Del Citerna F
G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
[TBL] [Abstract][Full Text] [Related]
13. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction.
Parikka H; Toivonen L; Naukkarinen V; Tierala I; Pohjola-Sintonen S; Heikkilä J; Nieminen MS
Eur Heart J; 1999 Jan; 20(2):111-20. PubMed ID: 10099907
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.
Raghu C; Peddeswara Rao P; Seshagiri Rao D
Int J Cardiol; 1999 Dec; 71(3):209-15. PubMed ID: 10636525
[TBL] [Abstract][Full Text] [Related]
15. Acute myocardial infarction without thrombolytic therapy: beneficial effects of magnesium sulfate.
Shechter M; Hod H; Chouraqui P; Kaplinsky E; Rabinowitz B
Herz; 1997 Jun; 22 Suppl 1():73-6. PubMed ID: 9259191
[TBL] [Abstract][Full Text] [Related]
16. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.
Cooper HA; Domanski MJ; Rosenberg Y; Norman J; Scott JH; Assmann SF; McKinlay SM; Hochman JS; Antman EM;
Am Heart J; 2004 Dec; 148(6):1012-9. PubMed ID: 15632887
[TBL] [Abstract][Full Text] [Related]
17. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
[TBL] [Abstract][Full Text] [Related]
18. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of magnesium sulfate in acute myocardial infarction.
Shechter M; Hod H; Marks N; Behar S; Kaplinsky E; Rabinowitz B
Am J Cardiol; 1990 Aug; 66(3):271-4. PubMed ID: 2195862
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Woods KL; Fletcher S
Lancet; 1994 Apr; 343(8901):816-9. PubMed ID: 7908076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
